Drug Pricing Regulation
-
{
- All
- News
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
India's Cancer Affordability: Cheaper Drugs Alone Cannot Save More Lives
Price control is not the answer to India's cancer problem. What it needs is a comprehensive strategy of transparent pharmaceutical pricing, indigenous innovation, rational treatment protocols, evidence-based reimbursement and equitable health care delivery.
-
Cancer Drug Prices Slashed By Over 90%, But Experts Say One-Time Cuts Won't End Overpricing
Public health group, Jan Swastha Abhiyaan has demanded cost-based price controls, permanent caps on trade margins and independent verification of cancer drug prices.
-
Supreme Court Flags Massive Gap Between Medicine MRP And Retailer Cost, Asks Government, "Allowing This To Happen?"
The Court was hearing a public interest litigation (PIL) filed by advocate Kishan Chand Jain seeking mandatory generic drug prescriptions, strict initial price controls on non-scheduled medicines, and statutory margin caps on medical devices under the Drug Price Control Order (DPCO).
-
Government Caps Cancer Drug Trade Margins At 30%, Supreme Court Asks: Why Regulate Only Cancer Medicines?
While the proposed cap could reduce cancer treatment costs, the Supreme Court wants the government to explain why similar restrictions cannot be considered for other medicines and medical devices.
-
Drug Price Regulator Caps Prices Of Liquid Medical Oxygen, Medical Oxygen Cylinders
The demand for medical oxygen has increased by almost four times due to the current Covid-19 situation.
-
NPPA Fixes Prices Of 58 Drug Formulations
The list include drugs used for treating cardiac conditions, Hepatitis C and diabetes.
-
Hillary Clinton Win May Pose Pricing Challenges For Pharma Firms: Report
Both US presidential candidates have argued in favour of allowing the US government's Medicare programme, which accounts for over 20 per cent of total US drug spend, to directly negotiate drug prices with manufacturers.
-
126 Drugs Cheaper by Over 40% as Government Fixes Ceiling
Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament was informed on Friday.
-
Government Expands Drug Price Control List to Include 2 Antibiotics
The government has extended price caps to an additional two antibiotics, in its latest effort to improve the affordability of medicines.
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
India's Cancer Affordability: Cheaper Drugs Alone Cannot Save More Lives
Price control is not the answer to India's cancer problem. What it needs is a comprehensive strategy of transparent pharmaceutical pricing, indigenous innovation, rational treatment protocols, evidence-based reimbursement and equitable health care delivery.
-
Cancer Drug Prices Slashed By Over 90%, But Experts Say One-Time Cuts Won't End Overpricing
Public health group, Jan Swastha Abhiyaan has demanded cost-based price controls, permanent caps on trade margins and independent verification of cancer drug prices.
-
Supreme Court Flags Massive Gap Between Medicine MRP And Retailer Cost, Asks Government, "Allowing This To Happen?"
The Court was hearing a public interest litigation (PIL) filed by advocate Kishan Chand Jain seeking mandatory generic drug prescriptions, strict initial price controls on non-scheduled medicines, and statutory margin caps on medical devices under the Drug Price Control Order (DPCO).
-
Government Caps Cancer Drug Trade Margins At 30%, Supreme Court Asks: Why Regulate Only Cancer Medicines?
While the proposed cap could reduce cancer treatment costs, the Supreme Court wants the government to explain why similar restrictions cannot be considered for other medicines and medical devices.
-
Drug Price Regulator Caps Prices Of Liquid Medical Oxygen, Medical Oxygen Cylinders
The demand for medical oxygen has increased by almost four times due to the current Covid-19 situation.
-
NPPA Fixes Prices Of 58 Drug Formulations
The list include drugs used for treating cardiac conditions, Hepatitis C and diabetes.
-
Hillary Clinton Win May Pose Pricing Challenges For Pharma Firms: Report
Both US presidential candidates have argued in favour of allowing the US government's Medicare programme, which accounts for over 20 per cent of total US drug spend, to directly negotiate drug prices with manufacturers.
-
126 Drugs Cheaper by Over 40% as Government Fixes Ceiling
Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament was informed on Friday.
-
Government Expands Drug Price Control List to Include 2 Antibiotics
The government has extended price caps to an additional two antibiotics, in its latest effort to improve the affordability of medicines.
